GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY AND KEY SECONDARY ENDPOINTS IN THE PHASE 3 FINCH 1 RHEUMATOID ARTHRITIS STUDY

March 28, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search